These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35777029)

  • 1. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
    Ge L; Sun Q; Xia L; Xu X
    Medicine (Baltimore); 2022 Jul; 101(26):e29802. PubMed ID: 35777029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of NUF2 in breast cancer and its clinical significance].
    Sun J; Chen J; Wang Z; Deng Y; Liu L; Liu X
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):591-597. PubMed ID: 31140425
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Xie X; Jiang S; Li X
    Front Oncol; 2021; 11():621373. PubMed ID: 33767990
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
    Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
    Front Oncol; 2021; 11():656509. PubMed ID: 34178642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.
    Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
    Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
    Xu W; Wang Y; Wang Y; Lv S; Xu X; Dong X
    Int J Mol Med; 2019 Aug; 44(2):390-404. PubMed ID: 31198978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 8. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
    He XY; Zhao J; Chen ZQ; Jin R; Liu CY
    Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANP32E contributes to gastric cancer progression via NUF2 upregulation.
    Zhu X; Zou Y; Wu T; Ni J; Tan Q; Wang Q; Zhang M
    Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35795988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the expression of SLC30A family genes and prognosis in human gastric cancer.
    Guo Y; He Y
    Sci Rep; 2020 Oct; 10(1):18352. PubMed ID: 33110097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUF2 Promotes Breast Cancer Development as a New Tumor Stem Cell Indicator.
    Deng Y; Li J; Zhang Y; Hu H; Wan F; Min H; Zhou H; Gu L; Liao X; Zhou J; Zhou J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers.
    Jiang X; Jiang Y; Luo S; Sekar K; Koh CKT; Deivasigamani A; Dong Q; Zhang N; Li S; Hao F; Goh BKP; Ooi LL; Wang Y; Hui KM
    Cancer Res Treat; 2021 Oct; 53(4):944-961. PubMed ID: 33421974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer.
    Lv S; Xu W; Zhang Y; Zhang J; Dong X
    Int J Oncol; 2020 Dec; 57(6):1358-1367. PubMed ID: 33173994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer.
    Guo F; Kong WN; Feng YC; Lv J; Zhao G; Wu HL; Ai L; Zhou X; Cai XL; Sun W; Ma XM
    Technol Cancer Res Treat; 2020; 19():1533033820970688. PubMed ID: 33167799
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Jiang F; Huang X; Yang X; Zhou H; Wang Y
    Front Oncol; 2022; 12():795971. PubMed ID: 35814368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
    Liu J; Liu Z; Zhang X; Gong T; Yao D
    BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
    Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
    Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.